Phase I Pilot Clinical Trial of Antenatal Maternally Administered Melatonin to Decrease the Level of Oxidative Stress in Human Pregnancies Affected by Preeclampsia

Euan Wallace et al. published in Methods in Molecular Biology.

Read article here.